I agree that this site is using cookies. You can find further informations here.
X
Spoletini, G.
145  results:
Search for persons X
?
1

WS07.06 Maternal and foetal outcomes following elexacaftor/..:

Etherington, C. ; Shimmin, D. ; Clifton, I...
Journal of Cystic Fibrosis.  23 (2024)  - p. S14 , 2024
Link: https://doi.org/10.1016/..
 
?
2

P230 Real-life impact on elexacaftor/tezacaftor/ivacaftor (..:

Abel, E. ; Clifton, I. ; Spoletini, G....
Journal of Cystic Fibrosis.  23 (2024)  - p. S139-S140 , 2024
Link: https://doi.org/10.1016/..
 
?
3

P303 Prevalence and clinical presentation of inflammatory b..:

Abel, E. ; Stone, L. ; Spoletini, G....
Journal of Cystic Fibrosis.  23 (2024)  - p. S161 , 2024
Link: https://doi.org/10.1016/..
 
?
4

P241 Safety and efficacy of meropenem-vaborbactam in people..:

Abdalaziz, M. ; Saumtally, H. ; Spoletini, G....
Journal of Cystic Fibrosis.  23 (2024)  - p. S142-S143 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Upadacitinib in the treatment of difficult‐to‐treat psoriat..:

Graceffa, D. ; Sperati, F. ; Lora, V....
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
6

P283 Exclusion value and comfort level during colonoscopy i..:

Spoletini, G. ; Shimmin, D. ; Etherington, C....
Journal of Cystic Fibrosis.  23 (2024)  - p. S156 , 2024
Link: https://doi.org/10.1016/..
 
?
7

EPS5.05 Colonoscopy and polyp detection in a large cohort o..:

Spoletini, G. ; Shimmin, D. ; Etherington, C....
Journal of Cystic Fibrosis.  23 (2024)  - p. S47-S48 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Changes in liver biochemistry and tacrolimus levels followi..:

Tachtatzis, P ; Spoletini, G ; Clifton, I..
Journal of Cystic Fibrosis.  23 (2024)  1 - p. 99-102 , 2024
Link: https://doi.org/10.1016/..
 
?
9

P284 Patient satisfaction and experience of an intensive bo..:

Shimmin, D. ; Spoletini, G. ; Yusuf, B....
Journal of Cystic Fibrosis.  23 (2024)  - p. S156 , 2024
Link: https://doi.org/10.1016/..
 
?
10

WS13.03 Anti-inflammatory effects of elexacaftor/tezacaftor..:

Jarosz-Griffiths, H.H. ; Gillgrass, L. ; Caley, L.R....
Journal of Cystic Fibrosis.  23 (2024)  - p. S24 , 2024
Link: https://doi.org/10.1016/..
 
?
11

P295 Patient satisfaction and experience of having a dedica..:

Yusuf, B. ; Shimmin, D. ; Spoletini, G....
Journal of Cystic Fibrosis.  23 (2024)  - p. S159-S160 , 2024
Link: https://doi.org/10.1016/..
 
?
12

P021 Change in sweat chloride concentration following elexa..:

Saumtally, H.A. ; Williams, E. ; Gillgrass, L....
Journal of Cystic Fibrosis.  22 (2023)  - p. S70 , 2023
Link: https://doi.org/10.1016/..
 
?
13

WS12.06 The changing landscape of tube feeding in the post ..:

May, L. ; Shimmin, D. ; Clifton, I....
Journal of Cystic Fibrosis.  22 (2023)  - p. S25 , 2023
Link: https://doi.org/10.1016/..
 
?
14

P366 Developing an in-house and integrated sweat testing se..:

Gillgrass, L. ; Haigh, L. ; Pollard, K....
Journal of Cystic Fibrosis.  22 (2023)  - p. S176 , 2023
Link: https://doi.org/10.1016/..
 
?
15

P063 Dermatological reactions to elexacaftor/tezacaftor/iva..:

Sawant, A.P. ; Spoletini, G. ; Saumtally, H.A....
Journal of Cystic Fibrosis.  22 (2023)  - p. S82 , 2023
Link: https://doi.org/10.1016/..
 
1-15